Bill Commons

PA HB 2747

in committee

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Pennsylvania · 2025-2026 Regular Session (209th General Assembly)

Quick answers

Did PA HB 2747 pass?

Not yet. PA HB 2747 is in committee as of 2026-08-25 and has not come to a final vote. Latest recorded action (2026-08-25): Referred to Judiciary

What is PA HB 2747 about?

PA HB 2747 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.”.

Who sponsors PA HB 2747?

Doyle Heffley is the primary sponsor of PA HB 2747, joined by 2 cosponsors.

Introduced
—
Latest action
2026-08-25 — Referred to Judiciary
Bill type
bill
Last updated
—

Sponsors

  • Doyle Heffleyprimary
  • Andrew Kuzmacosponsor
  • Dan Moulcosponsor

Committees

Not provided by source.

Action timeline

  1. 2026-08-25

    Referred to Judiciary

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

https://www.palegis.us/legislation/bills/2025/hb2747

Attribution

Data from openstates_api_sync, retrieved 2026-08-26T22:59:30.666556Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 2747. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.